Carnitine PT II Deficiency and Cerebral Dysgenesis
A newborn female infant with neonatal lethal multiorgan carnitine palmitoyltransferase II (CPT II) defiency is reported from the Departments of Medicine and Pathology, Children’s Hospital, Boston, MA; and the Department of Pharmacology and Medicine, Case Western Reserve University, VA Medical Center...
Main Author: | J Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
1995-10-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/2567 |
Similar Items
-
Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features
by: Diana Lehmann, et al.
Published: (2017-01-01) -
Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency
by: Leila Motlagh Scholle, et al.
Published: (2019-03-01) -
Carnitine Inborn Errors of Metabolism
by: Mohammed Almannai, et al.
Published: (2019-09-01) -
Unrecognized High Occurrence of Genetically Confirmed Hereditary Carnitine Palmitoyltransferase II Deficiency in an Austrian Family Points to the Ongoing Underdiagnosis of the Disease
by: Christina Zach, et al.
Published: (2019-05-01) -
Schizophrenic Psychosis Symptoms in a Background of Mild-to-Moderate Carnitine Palmitoyltransferase II Deficiency: A Case Report
by: Rochelle N. Wickramasekara, et al.
Published: (2020-10-01)